CompletedNot Applicable

Activating Collaborative CIS Support Via Targeted Provider Mailing

United States254 participantsStarted 2006-10

Plain-language summary

RATIONALE: Receiving a reminder letter from their doctor with questions to ask the Cancer Information Service may be more effective than a standard reminder letter in helping patients who have had an abnormal Pap test keep their follow-up colposcopy appointment. PURPOSE: This randomized clinical trial is studying a personalized letter with Cancer Information Service support to see how well it works compared with a standard reminder letter in women scheduled for colposcopy after an abnormal Pap test.

Who can participate

Age range18 Years – 100 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: DISEASE CHARACTERISTICS: * Received an abnormal Pap test result * Scheduled for a colposcopy within 6 months of their Pap test at either the Erie Family Health Center or the Prentice Ambulatory Clinic PATIENT CHARACTERISTICS: * Female * Able to communicate in either English or Spanish * Clinic staff will review patient charts to determine eligibility PRIOR CONCURRENT THERAPY: * Not specified Exclusion criteria: * \<18 years * unable to communicate in English or Spanish * no address to which a letter can be mailed

What they're measuring

Patient Satisfaction in the 2 Interventions

Timeframe: within 6 months of PAP

CIS Experience of Patients in Arm II and the Effect of the Intervention on Their Follow-up Colposcopy

Timeframe: within 6 months of PAP

Trial details

NCT IDNCT00873288

SponsorNorthwestern University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2008-11

Results submitted2016-10-04

View on ClinicalTrials.gov More Precancerous Condition trials